Immunohistochemical staining of a tissue microarray containing 102 CRC clinical samples (Fig. 7a) demonstrated that the expression of these four genes was positively associated with tumor-infiltrating immune cell markers such as CD4, CD8, CD19, and CD68 (Fig. 7b; Table 6). This evidence concerns the gene CD4 and neoplasm.